This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Deutsche Bank analyst Corinne Blanchard initiated coverage on Clearway Energy, Inc. CWEN with a Buy rating and announced a price target of $38. Clearway Energy shares closed at $29.85 on Monday. See how other analysts view this stock.
  • Stifel analyst Alex Thompson initiated coverage on Crinetics Pharmaceuticals, Inc. CRNX with a Buy rating and announced a price target of $60. Crinetics Pharmaceuticals shares closed at $35.94 on Monday. See how other analysts view this stock.
  • Evercore ISI Group analyst John Pancari initiated coverage on OneMain Holdings, Inc. OMF with an In-Line rating and announced a price target of $58. OneMain shares closed at $52.87 on Monday. See how other analysts view this stock.
  • Jefferies analyst Kambiz Yazdi initiated coverage on Avalo Therapeutics, Inc. AVTX with a Buy rating and announced a price target of $23. Avalo Therapeutics shares closed at $7.63 on Monday. See how other analysts view this stock.
  • Guggenheim analyst Vamil Divan initiated coverage on Assembly Biosciences, Inc. ASMB with a Buy rating and announced a price target of $31. Assembly Biosciences shares closed at $11.12 on Monday.  See how other analysts view this stock.

Read This Next:

Image: Shutterstock

ASMB Logo
ASMBAssembly Biosciences Inc
$9.07-0.11%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
12.95
Growth
-
Quality
-
Value
76.35
Price Trend
Short
Medium
Long
Got Questions? Ask
Which energy stocks might surge with CWEN?
How could Crinetics Pharmaceuticals expand its market?
What other pharmaceuticals will follow CRNX's lead?
Will OneMain Holdings benefit from industry trends?
Which biotech companies are on the cusp of breakthroughs?
Could Avalo Therapeutics lead in new treatment options?
What impact does ASMB's rating have on biotech investments?
Are there upcoming trends in energy sectors to watch?
Which analysts are most accurate for future stock picks?
What other initiations should investors pay attention to?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: